Bristol-Myers Squibb Co. (BMY) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for BMY. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|
| Vanguard | 202,276,467 | $11.7B | INCREASED |
| BlackRock | 180,384,994 | $10.4B | INCREASED |
| State Street | 102,408,940 | $5.9B | INCREASED |
| JPMorgan Chase | 71,713,442 | $4.2B | DECREASED |
| Charles Schwab Investment Management | 67,595,177 | $3.9B | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|
| Cristian Massacesi (EVP,Chief Med Offr,Head of Dev) | SELL | 6,249 | $403K | 2026-09-09 |
| Bartie Wendy Short (EVP, Corporate Affairs) | TAX-W | 633 | $42K | 2026-09-01 |
| Bartie Wendy Short (EVP, Corporate Affairs) | EXERCISE | 1,236 | $83K | 2026-09-01 |
| Phil M Holzer (SVP and Controller) | SELL | 500 | $34K | 2026-08-25 |
| Cari Gallman (EVP, General Counsel) | TAX-W | 543 | $35K | 2026-08-01 |
Recent Congressional Trades
Full institutional holdings, insider history, and congressional trades for Bristol-Myers Squibb Co. on SentiSense.